Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

National Taiwan University Hospital ( Site 0211), Taipei

Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 0216), Kaoshiung

Bajcsy Zsilinszki Korhaz es Rendelointezet ( Site 0509), Budapest

Orszagos Onkologiai Intezet ( Site 0503), Budapest

Uzsoki Utcai Korhaz ( Site 0508), Budapest

Rigshospitalet ( Site 0680), Copenhagen

Macquarie University ( Site 0151), North Ryde

Herlev Hospital ( Site 0681), Herlev

Austin Health-Austin Hospital ( Site 0154), Heidelberg

Monash Health ( Site 0160), Clayton

Peninsula Health Frankston Hospital ( Site 0153), Frankston

Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Okta-Klinikai Onkológiai és Sugárterápiás Ce, Miskolc

Mater Misericordiae Ltd ( Site 0158), South Brisbane

Odense Universitetshospital ( Site 0682), Odense

Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 0507), Szolnok

Bacs-Kiskun Megyei Korhaz ( Site 0510), Kecskemét

Somogy Megyei Kaposi Mor Oktato Korhaz ( Site 0504), Kaposvár

Aarhus Universitets hospital ( Site 0683), Aarhus N

Aalborg Universitets Hospital ( Site 0684), Aalborg

Markusovszky Egyetemi Oktatokorhaz ( Site 0502), Szombathely

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0002), New York

National Cancer Center ( Site 0196), Goyang-si

Taipei Veterans General Hospital ( Site 0212), Taipei

St. Peter's Hospital Cancer Care Center ( Site 0042), Albany

Hopital de la Timone ( Site 0246), Marseille

Hospital Teresa Herrera - Chuac ( Site 0357), A Coruña

Helios Kliniken Schwerin GmbH ( Site 0278), Schwerin

Thomas Jefferson University Hospital ( Site 0051), Philadelphia

Ospedale San Raffaele-Oncologia Medica ( Site 0309), Milan

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 0301), Milan

ASST Grande Ospedale Metropolitano Niguarda ( Site 0307), Milan

Universitaetsklinikum Hamburg-Eppendorf ( Site 0282), Hamburg

Virginia Cancer Institute ( Site 0099), Richmond

Universitaetsklinikum Schleswig-Holstein-Campus Lubeck ( Site 0277), Lübeck

Staedtisches Krankenhaus Kiel GmbH ( Site 0285), Kiel

Hospital La Princesa ( Site 0862), Madrid

Hospital Universitario Gregorio Maranon ( Site 0352), Madrid

Hospital Universitario HM Sanchinarro ( Site 0356), Madrid

CHIC Quimper ( Site 0245), Quimper

Medical University of South Carolina-Hollings Cancer Center ( Site 0029), Charleston

Northwest Georgia Oncology Centers PC ( Site 0707), Marietta

Clinique Pasteur ( Site 0252), Tolouse

CHU de Bordeaux- Hopital Saint Andre ( Site 0235), Bordeaux

Centro di Riferimento Oncologico CRO ( Site 0304), Aviano

Centre de Cancerologie du Grand Montpellier ( Site 0249), Montpellier

Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 0454), Istanbul

Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 0459), Istanbul

Chungnam National University Hospital ( Site 0195), Daejeon

Universitaetsklinikum Giessen und Marburg GmbH ( Site 0284), Marburg

Ege Universitesi Tulay Aktas Onkoloji Hastanesi ( Site 0462), Izmir

Universitaetsmedizin Goettingen ( Site 0281), Göttingen

Ospedale Borgo Roma-Oncologia ( Site 0308), Verona

Policlinico S. Orsola - Malpighi (Bologna) ( Site 0302), Bologna

China Medical University Hospital ( Site 0213), Taichung

Taichung Veterans General Hospital ( Site 0214), Taichung

Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi ( Site 0456), Konya

Centre Rene Gauducheau ICO ( Site 0250), Saint-Herblain

Universitaetsklinikum Essen ( Site 0274), Essen

Karmanos Cancer Institute ( Site 0712), Detroit

Institut de Cancerologie de l Ouest Site Paul Papin ( Site 0236), Angers

Centre D Oncologie de Gentilly ( Site 0240), Nancy

Sakarya Universitesi Tip Fakultesi Arastirma Hastanesi ( Site 0460), Sakarya

Chonnam National University Hwasun Hospital ( Site 0194), Hwasun Gun

Joliet Oncology Hematology ( Site 0091), Joliet

University of Chicago ( Site 0039), Chicago

Quincy Medical Group ( Site 0022), Quincy

Mercy Hospital Saint Louis - David C. Pratt Cancer Center ( Site 0095), St Louis

Centre Hospitalier de la Cote Basque ( Site 0239), Bayonne

Institut de Cancerologie Strasbourg Europe ( Site 0232), Strasbourg

Centre Leon Berard ( Site 0244), Lyon

Istituto Tumori Giovanni Paolo II ( Site 0306), Bari

Assaf Harofeh Medical Center ( Site 0556), Ẕerifin

National Cheng Kung University Hospital ( Site 0215), Tainan City

Klinikum der Eberhard-Karls-Universitaet Tuebingen ( Site 0271), Tübingen

Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0774), Tulsa

Institut Curie ( Site 0237), Paris

Baylor Scott & White Medical Center - Temple ( Site 0706), Temple

Kaohsiung Chang Gung Memorial Hospital ( Site 0217), Kaohsiung City

Banner MD Anderson Cancer Center ( Site 0016), Gilbert

CHD Vendee-onco-hematologie ( Site 0251), La Roche-sur-Yon

CHU Poitiers ( Site 0253), Poitiers

Comprehensive Cancer Centers of Nevada ( Site 0005), Las Vegas

John Wayne Cancer Institute ( Site 0017), Santa Monica

University of California Irvine Medical Center ( Site 0078), Orange

Community Cancer Institute ( Site 0777), Clovis

Institut Gustave Roussy ( Site 0243), Villejuif

Azienda Ospedaliera per l Emergenza Cannizzaro ( Site 0305), Catania

Seattle Cancer Care Alliance ( Site 0003), Seattle

Cancer Care Northwest ( Site 0009), Spokane

Peking University First Hospital ( Site 0726), Beijing

Fifth Medical Center of CPLA General Hospital ( Site 0732), Beijing

Peking University Third Hospital ( Site 0727), Beijing

Russian Scientific Center of Roentgenoradiology ( Site 0424), Moscow

Central Clinical Hospital with Polyclinic ( Site 0415), Moscow

Medical Rehabilitation Center ( Site 0411), Moscow

Yaroslavl Regional SBIH Clinical Oncology Hospital ( Site 0414), Yaroslavl

Harbin Medical University Cancer Hospital ( Site 0750), Harbin

Murmansk Regional Oncology Dispensary ( Site 0420), Murmansk

GBUZ Leningrad Regional Clinical Oncology Dispensary ( Site 0426), Kuzmolovskiy Settlement

Clinical Hospital Saint Luka ( Site 0421), Saint Petersburg

Fudan University Shanghai Cancer Center ( Site 0721), Shanghai

Zhongshan Hospital Fudan University ( Site 0725), Shanghai

Nanjing Drum Tower Hospital ( Site 0737), Nanjing

Second Affiliated Hospital, Zhejiang University ( Site 0734), Hangzhou

Zhejiang Provincial People's Hospital ( Site 0735), Hangzhou

The First Affiliated Hospital of Xiamen University ( Site 0743), Xiamen

Chongqing Cancer Hospital ( Site 0741), Chongging

Hunan Cancer Hospital ( Site 0745), Changsha

Hubei Cancer Hospital ( Site 0744), Wuhan

Sun Yat-Sen University Cancer Center ( Site 0752), Guangdong

The First Affiliated Hospital of Guangzhou Medical University ( Site 0749), Guangzhou

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ( Site 0746), Guangzhou

Volga District Medical Center Federal Medical and Biological Agency ( Site 0413), Nizhny Novgorod

Omsk Clinical Oncology Dispensary ( Site 0418), Omsk

The First Affiliated Hospital of Xi an Jiaotong University ( Site 0738), Xian

Cancer Hospital Affiliated to Xinjiang Medical University ( Site 0751), Ürümqi

Ha Emek Medical Center ( Site 0560), Afula

Rambam Medical Center ( Site 0552), Haifa

Meir Medical Center ( Site 0554), Kfar Saba

Rabin Medical Center ( Site 0553), Petah Tikva

Sheba Medical Center ( Site 0551), Ramat Gan

Sourasky Medical Center ( Site 0561), Tel Aviv

Assuta Ashdod Public ( Site 0562), Ashdod

Shaare Zedek Medical Center ( Site 0559), Jerusalem

Hadassah Ein Kerem Medical Center ( Site 0558), Jerusalem

New England Cancer Specialists ( Site 0047), Scarborough

Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 0577), Berazategui

Centro de Urología CDU ( Site 0590), Buenos Aires

Instituto Medico Alexander Fleming ( Site 0578), Buenos Aires

Centro Medico Dra De Salvo ( Site 0593), Buenos Aires

Centro de Investigaciones Clinicas - Clinica Viedma ( Site 0585), Viedma

Centro Oncológico de Rosario ( Site 0584), Rosario

Instituto de Investigaciones Metabolicas ( Site 0589), Buenos Aires

CEMAIC ( Site 0581), Córdoba

Centro Oncologico de Integracion Regional. COIR ( Site 0576), Mendoza

Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0101), Hamilton

Lakeridge Health ( Site 0103), Oshawa

Sunnybrook Research Institute ( Site 0106), Toronto

CHUQ-Univ Laval-Hotel Dieu de Quebec ( Site 0104), Québec

CIUSSS de l Estrie Centre Hospitalier Universitaire de Sherbrooke ( Site 0102), Sherbrooke

Azienda Ospedaliera Santa Maria ( Site 0303), Terni

Hirosaki University Hospital ( Site 0123), Hirosaki

National Cancer Center Hospital East ( Site 0128), Kashiwa

Ehime University Hospital ( Site 0137), Tōon

Sapporo Medical University Hospital ( Site 0122), Sapporo

University of Tsukuba Hospital ( Site 0126), Tsukuba

Kitasato University Hospital ( Site 0129), Sagamihara

Nara Medical University Hospital ( Site 0133), Kashihara

Saitama Medical University International Medical Center ( Site 0125), Hidaka

Yamaguchi University Hospital ( Site 0135), Ube

Akita University Hospital ( Site 0124), Akita

Chiba Cancer Center ( Site 0127), Chiba

Nagasaki University Hospital ( Site 0136), Nagasaki

Osaka City University Hospital ( Site 0132), Osaka

Tokushima University Hospital ( Site 0134), Tokushima

Medical Hospital, Tokyo Medical And Dental University ( Site 0130), Tokyo

Ziekenhuis Rijnstate ( Site 0342), Arnhem

Maastricht Universitair Medisch Centrum - MUMC ( Site 0334), Maastricht

VieCuri Medisch Centrum ( Site 0340), Venlo

Amphia Ziekenhuis Breda ( Site 0331), Breda

Deventer Ziekenhuis ( Site 0341), Deventer

Erasmus MC ( Site 0332), Rotterdam

Haga Ziekenhuis ( Site 0333), The Hague

St. Antonius Ziekenhuis ( Site 0335), Utrecht

Szpital Wojewodzki ( Site 1062), Tarnów

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego ( Site 0535), Wroclaw

Europejskie Centrum Zdrowia Otwock ( Site 0532), Otwock

Urologica Praktyka Lekarska Adam Marcheluk ( Site 0543), Siedlce

Luxmed Onkologia sp. z o. o. ( Site 0541), Warsaw

Szpital Miejski im. Jana Pawła II w Bielsku-Białej ( Site 0542), Bielsko-Biala

Korea University Anam Hospital ( Site 0197), Seoul

Seoul National University Hospital ( Site 0191), Seoul

Severance Hospital ( Site 0192), Seoul

Veterans Health Service Medical Center ( Site 0198), Seoul

Samsung Medical Center ( Site 0193), Seoul

Institut Catala d Oncologia Hospital Germans Trias i Pujol ( Site 0351), Badalona

ICO L Hospitalet ( Site 0361), L'Hospitalet de Llobregat

Xarxa Assistencial Universitaria Manresa ( Site 0354), Manresa

Hospital Infanta Cristina ( Site 0355), Badajoz

Hospital General Universitari Vall d Hebron ( Site 0358), Barcelona

Cukurova Universitesi Tıp Fakultesi Balcalı Hastanesi ( Site 0457), Adana

Ankara Sehir Hastanesi ( Site 0455), Ankara

Antalya Memorial Hospital Department of Medical Oncology ( Site 0461), Antalya

Weston Park Hospital ( Site 0387), Sheffield

Queens Hospital-Purple Zone ( Site 0377), Romford

Lister Hospital ( Site 0376), Stevenage

Kent and Canterbury Hospital ( Site 0390), Canterbury

Royal Preston Hospital ( Site 0379), Preston

Saint Bartholomew s Hospital - London ( Site 0386), London

University College London Hospital NHS Foundation Trust ( Site 0380), London

Imperial Healthcare NHS Trust Charing Cross Hospital ( Site 0378), London

Nottingham University Hospital NHS Trust ( Site 0383), Nottingham

Derriford Hospital ( Site 0388), Plymouth

Royal Stoke University Hospital Univ. Hosps of North Midlands NHST ( Site 0392), Stoke-on-Trent